ZOGHBI HUDA Y sold 49.0% of their position (1.64K shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.28M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.64K
Price / share
$376.69
Trade value
$617.02K
% of position
Common Stock
Shares
−49.00
Price / share
$774.68
Trade value
$37.96K
% of position
Common Stock
Shares
−50.00
Price / share
$775.50
Trade value
$38.77K
% of position
Common Stock
Shares
−53.00
Price / share
$778.47
Trade value
$41.26K
% of position
Common Stock
Shares
−208.00
Price / share
$779.55
Trade value
$162.15K
% of position
Common Stock
Shares
−331.00
Price / share
$780.45
Trade value
$258.33K
% of position
Common Stock
Shares
−209.00
Price / share
$781.28
Trade value
$163.29K
% of position
Common Stock
Shares
−298.00
Price / share
$782.10
Trade value
$233.07K
% of position
Common Stock
Shares
−220.00
Price / share
$783.29
Trade value
$172.32K
% of position
Common Stock
Shares
−160.00
Price / share
$784.45
Trade value
$125.51K
% of position
Common Stock
Shares
−56.00
Price / share
$785.61
Trade value
$43.99K
% of position
Common Stock
Shares
−4.00
Price / share
$790.00
Trade value
$3.16K
% of position
Net shares
+0.00
Net value
-$662.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | M · Option Exercise | +1.64K | $376.69 | $617.02K | 96.2% | 1.70K | 3.34K |
| Common Stock Direct | 2/19/2026 | S · Sale | −49.00 | $774.68 | $37.96K | 1.5% | 3.34K | 3.29K |
| Common Stock Direct | 2/19/2026 | S · Sale | −50.00 | $775.50 | $38.77K | 1.5% | 3.29K | 3.24K |
| Common Stock Direct | 2/19/2026 | S · Sale | −53.00 | $778.47 | $41.26K | 1.6% | 3.24K | 3.19K |
| Common Stock Direct | 2/19/2026 | S · Sale | −208.00 | $779.55 | $162.15K | 6.5% | 3.19K | 2.98K |
| Common Stock Direct | 2/19/2026 | S · Sale | −331.00 | $780.45 | $258.33K | 11.1% | 2.98K | 2.65K |
| Common Stock Direct | 2/19/2026 | S · Sale | −209.00 | $781.28 | $163.29K | 7.9% | 2.65K | 2.44K |
| Common Stock Direct | 2/19/2026 | S · Sale | −298.00 | $782.10 | $233.07K | 12.2% | 2.44K | 2.14K |
| Common Stock Direct | 2/19/2026 | S · Sale | −220.00 | $783.29 | $172.32K | 10.3% | 2.14K | 1.92K |
| Common Stock Direct | 2/19/2026 | S · Sale | −160.00 | $784.45 | $125.51K | 8.3% | 1.92K | 1.76K |
| Common Stock Direct | 2/19/2026 | S · Sale | −56.00 | $785.61 | $43.99K | 3.2% | 1.76K | 1.71K |
| Common Stock Direct | 2/19/2026 | S · Sale | −4.00 | $790.00 | $3.16K | 0.2% | 1.71K | 1.70K |
| Total | +0.00 | -$662.79K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
1.64K shares
Shares
−1.64K
Strike price
376.69
Held after
800.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.64K shares | 2/19/2026 | M · Option Exercise | −1.64K | 376.69 | — | 800.00 |